(AETOS Wire) -- Octapharma announced today that the European Medicines Agency (EMA) has approved an extension of marketing authorisation for its human cell line-derived recombinant factor VIII (rFVIII) product, Nuwiq®. New single dose vial strengths of 2500, 3000 and 4000 International Units (IU) will be available in Europe, in addition to the current strengths of 250, 500, 1000 and 2000 IU.

The new Nuwiq®"...

Brightree, the leading provider of cloud-based software helping post-acute care companies improve business performance and patient outcomes, announced the release of a new solution that allows home medical equipment (HME) providers to digitally receive orders from more than 62,000 providers using athenaClinicals within the athenahealth network, the same way doctors have long referred patients to other specialists. Before eReferral Management, physician and HME staff had to manually send, receive and process referrals and related documents via faxing and phone calls. Now, any office that uses athenahealth, a leading provider of network-enabled services for hospital and ambulatory clients nationwide, can refer patients to an HME provider the same way that they refer patients to other care settings, forwarding equipment orders directly from their electronic health records (EHR) system to the......

(AETOS Wire) -- Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo Patient State Index (PSi), a processed EEG parameter provided by SedLine® brain function monitoring (in this study, first generation SedLine), to Medtronic Bispectral Index (BIS™) in monitoring the depth of anesthesia of two groups of patients: healthy volunteers undergoing hepatotomy for liver donation and cirrhotic patients undergoing liver resection. The researchers found “excellent” agreement between the two methods as well as similar sevoflurane consumption, and found that PSi 1.0 was less affected by electrocautery.1 In the study, Dr. Yassen and colleagues at Menoufia University in Shibin El Kom, Egypt, sought to test agreement between two brain function monitoring indices, Masimo PSi and Medtronic BIS. They monitored......

Pale and speaking breathlessly, Jenan Sabea describes the horrific pain she felt in her stomach two weeks ago which prompted rushing her to hospital.

“I was screaming, crying. I was kicking on the floor, kicking hard,” she says. Jenan called an ambulance, which transferred her to the Salaheddin General Hospital in Tikrit, Iraq, about 90 minutes away. There, she was immediately attended in the five-month old Intensive Care Unit (ICU).

"...

(AETOS Wire)-- Acelity L.P. Inc., the world’s largest wound care company, and Crawford Healthcare, a rapidly growing UK-based advanced wound care and dermatology company, today announced an agreement for Acelity to acquire Crawford and all of its assets. Terms of the agreement were not disclosed.

With the acquisition of Crawford, Acelity expands its portfolio of advanced wound dressings (AWD), further"...

(AETOS Wire)-- Zebra Medical Vision (https://www.zebra-med.com/), the leading machine and deep learning startup, is announcing today it has raised $30M in C round funding, bringing the total investment in the company to $50M. In addition, the company is unveiling its Textray chest x-ray research (https://arxiv.org/abs/1806.02121) today, the most comprehensive AI research conducted on chest x-rays to date, which provides a glimpse into a future automated chest x-ray analysis product being developed by the company. This round of investment is led by aMoon Ventures with the participation of strategic healthcare investors Aurum, Johnson & Johnson Innovation JJDC Inc. and Intermountain Healthcare and leading global AI scientists Professor Fei Fei Lee and Richard Socher. These new investors are joining a list of existing investors Khosla Ventures, NVIDIA, Marc Benioff, OurCrowd and Dolby Ventures who also participated in this C round. The chest x-ray AI analytics product was trained using nearly 2 million images to identify 40 different common clinical findings. The......

(AETOS Wire)-- Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) announces that it has today entered into a term loan credit agreement for an aggregate principal amount of up to 7.5 billion USD with leading global financial institutions including J.P. Morgan Chase Bank N.A., Sumitomo Mitsui Banking Corporation, MUFG Bank, Ltd. and Mizuho Bank, Ltd. (the “Term Loan Credit Agreement”). The majority of the funding has been committed by Japanese institutions.

"...

(AETOS Wire)-- Philip Morris International Inc. (PMI) (NYSE: PM) today released the latest Scientific Update for Smoke-Free Products, a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes. We are focusing this issue on the growing body of independent research on our electrically heated tobacco product (EHTP, marketed as IQOS), the most advanced smoke-free alternative in our portfolio. The covered research comprises independent, peer-reviewed publications on smoke-free products that focus on EHTP, and also includes four recent government reports from the UK, the US, Germany, and the Netherlands. Other sections include an update on the assessment of each product in our smoke-free portfolio, recent R&D milestones and a compendium of PMI’s peer-reviewed publications on its smoke-free products this year. “We are happy to see growing interest in studying our smoke-free products and that the general trend among independent results is in line with our own research,” said Prof. Manuel Peitsch,......

(AETOS Wire)-- A new study reveals that shifting patients who are struggling with adherence to positive airway pressure (PAP) therapy to a more advanced bilevel device in the first 90 days of treatment is an effective tool for achieving adherence in well more than half of such cases.

This research, sponsored by ResMed (NYSE: RMD, ASX: RMD), was presented this week at SLEEP, an annual joint meeting of the"...

(AETOS Wire) -- Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, announced the National Bank of Kuwait (NBK) Children’s Hospital at Sabah Medical District is deploying Vocera technology throughout its new oncology building to improve care team communication and create a quieter, more healing environment for patients. Physicians, nurses, managers and support staff will be using the hands-free Vocera Badge and secure texting via the Vocera mobile app in its new center for hematology, cancer, and stem cell treatments. The project was timely executed in cooperation with Al Essa Group in Kuwait, a technology reseller in Kuwait. NBK Children’s Hospital is the first Ministry of Health hospital in Kuwait to deploy smart communication technology to improve care team collaboration, optimize operational efficiency, and elevate......